{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hyperprolinemia-type-2","columns":[{"gene":"","key":"population-7a1a2fe756052979dbaa","label":"Hyperprolinemia, type II","mondoId":"MONDO:0009401","onsetQualifier":null,"originColumnKey":"MONDO:0009401/OMIM:239510","originalViews":[{"key":"MONDO:0009401/OMIM:239510","label":"Hyperprolinemia, type II","scopeLabel":"OMIM:239510","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["1db383b77a0b583fd7c94bc6de96f64bf30531c53b2c3804bad25812e14f3412","57c3e4d56eb1c61238d0ad5ec247ef5191472c646b85e14ca0f63b85251f08bb","61c20d973e7fc9a9af66d4c4101a67d6172d36828d273dbd4342c8ac8b2a4829","622e6e7f997829a4ae42f93f150be7953b2efca692061dfe23b22e4c13578f53","b3aa59d423bf9970c161cc37ac6fd6a9a7705abd4e1352d8e782d4e8080e3e87","b93d8266847b8e9100956fee9906a92d3fa826c46d0a9aac56baf924c4ae4c17","da5be1516d3dccdef059af1ed705b8e38f6dbded738e05f92e3606476f1fe6f5","e9c228318291c9af7a6e67ebfe7890ccc96bf13fcd511483a2133f6896f09e1b","f9f92768b0a564d825969d88b041fd07742dbada026c71a225ded31a1c645a46"],"recordQualifiers":{},"scopeLabel":"OMIM:239510","sourceIds":["OMIM:239510"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-78058de8a4512787bff9","label":"Hyperprolinemia type 2","mondoId":"MONDO:0009401","onsetQualifier":null,"originColumnKey":"MONDO:0009401/ORPHA:79101","originalViews":[{"key":"MONDO:0009401/ORPHA:79101","label":"Hyperprolinemia type 2","scopeLabel":"ORPHA:79101","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["009490ec54c237857140f2d2388339fed704c4dba9fee141c9a2ff3246eabf3a","056db1f43462cf06d4f340c093267bf2d5d831c4dcbe5099d4c88ca3b5ea2649","07a800b1a0ed3ad9d73be8388ef90c6e1f0a24166ce49a31ca2c3b0bf95b320f","0bc4f0591ecfde28c4ae351c399bdfa438af87644fc637c28807629e719c339e","10926405d6afc89f4aae438d900cefffa445ca32015d584946f69cf3a5b6aa09","109da9ff1bb4b086d41e5b9993d5a3d4c605f0a7c618d45f0df978129ee1c46c","26129edf91bbb7ff607c3aa2599502eb503c0e182fe8f6a1311a9ec3486d3e25","2cf31e211a30cd4f95daaf8cb2ada591b7810ec1a27e782e774816ac0a79d6b7","353d5b5f82a52c93dbe0f94d24a2cc47558e34e08144802d5c78ed49e50729df","39b9d6845dc7d5e305ba7aa0e13bd23c951bd19150a64f201759c6ce5ee9e9e5","3e96c15d5290b0bfbeddac489a60e61714765d9fb22ebeedbd9a505e7d790557","42ba20a27935b3cd6c5ee5c7398e836b49679871459f7c59e96b31ca665a49b6","47cd07025337e5c66c4b6caf045dc24d507cb965a4becd905d1517905f5b93a1","48fcd76968415f7c519a2a7932e363e4db799ef7563023f3eaa98590677ac178","492c23ce893b0a5199dcf1b5d828fe0b396669ea977a3982e1dee687d2d20062","5312d34338881a8f05d598a5410c9a86d176bf31e8d2378731e1994a1deae8f6","563b43b1c32006cca0efe35eff0318612d4e645072878f801c76047da60dffe5","60f37c5fea73f413db5fefd6a9eac2dae01585dcb9a31ff4d28b1dbadbb7b6aa","62d87d658bb79abd290ea1644befa3058abe78dfbb0ce0228f35c6b013b76653","648fbe598469db3078bf837789d1b1c8ee717348e7223d219d866ab312fff74b","6bf8fcb73db7cef6c11e53759cf9e7b885075df455e654babce292562dc35b6a","71bc7967f08003c2257def5c828c6dbad6bf09c9d99d8b505a7be951434663ba","8b21838ff91d74bcd0ccd42fd8422e1f73e48ebb360bde1901bcc4fddce5460e","8b46d26b4e0dfc4cc8c6b8e15dde152b6cfd6aef954a78198dcb47a2a4265c61","9059d39298f004bf64853be6313b1199e235de1f32dbe63c14d700101ce4e51c","93247d71c693a1d5d6c53e59cadfcb12c78f1332ef14af1a401bd3dc0faeb098","93b7c5be0ddc44e4f61d5eb4a8e0555c984d6453766d18e509d48052daa1285f","967ce53ecbde59aa81fdf593990865e3b1134ca1e3da35ef0e2c9ff77c56ed29","97d68a71581e4b3539a3ce7f3311096b5c2406396eeacda5d4a357ab299c2168","98ee9e122f3e222ea1d10f7f490f6472fbb799518ee8f808eeffe7c683dc758c","99cf3a18d7d2e2e20567034bd070baf8f6012e63e1e6ae66caf70d619a497301","9affcdb101396527f71a0029543b537c42e6df1ccf97887013a6219516ed412c","a29a998eb8a02f50551329981a6f354dc6d12b1df13057253582d17c98e2d99c","b61139c502bf5ffeda2ee501ef3e9dcac4d5c6fc353d0a580e66c3bcd9e82b16","bec6c8adfd1329e5e8d53a57144db6e00f8a703cce9b557ce2a411b10cf8ab25","bf432ed20d555d79695f0479e4b76603c2e3241b736e51c4f3cb6aca9347617c","c17ac089fe86900392ce2837360757fb75441d494357bcdf3f2ef65aa341f815","c19f043669f43a1d179e80b24d2eb82719f4b0f1e669c4fc712eb3b971f9014d","cb71985df8f219f907ddf98a4174842fc2d9324b1c07820964ab9d997525ea27","cc8421fc857819bc69872ee6a7b1e41737781ace0dfdb1781aabf2bd2eaefb07","d9b43559f55b1a6f954ed465cbc2592d085f174a5e585b6bc0521813805fdec8","da49d892371c699f8f275771bf1a9cc388b0329ef0d264da5448aea6fbdfe80f","e4c57b1742227ae1c0008fdf5e6b7c19dc34d85bc18641f5f55f439c28be5809","e755abbb75cd672ffdeaf60ee9fd796c209dbe26447e605cce467a7d5ab75e2c","e9a3c22c26c1621dae59eda59cc01bfba882e51c3b860008d38b9b70d180fff2","ea24534cd0c349530b25740d12b4ce4830d63eac84ddfdc0f6ed161120a22079","ec31fc16fa23d5fe35515fbe8d89385b491b0d0a07a47111c220298e40a29996","f4f6f3e39fe7f5b519638b4c450c76f85cd98fd9c3a919547256faa07b00dba1","f6c3a173338fd13525bb26e4cfa202b4b385166afd301df75729a9eaeeac83cb","f80de4ecc455a0e46e7f1cdd4a0e184ab3f0d5c9c24a64816feeb570f6854dab","f8693de713df1c620f7de8a886c1c6ed69614d0f6cba6d3516a34abf511fad08"],"recordQualifiers":{},"scopeLabel":"ORPHA:79101","sourceIds":["ORPHA:79101"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-7a1a2fe756052979dbaa","population-78058de8a4512787bff9"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002027","HP:0002921","HP:0012379","HP:0000496","HP:0000718","HP:0000739","HP:0001284"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":1,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":60,"sourceGroups":{"omim":7,"orphanet":51,"published":2}},"features":[{"hpoId":"HP:0002027","label":"Abdominal pain","primary":true},{"hpoId":"HP:0002921","label":"Abnormal cerebrospinal fluid morphology","primary":true},{"hpoId":"HP:0012379","label":"Abnormal circulating enzyme concentration or activity","primary":true},{"hpoId":"HP:0000496","label":"Abnormality of eye movement","primary":true},{"hpoId":"HP:0000718","label":"Aggressive behavior","primary":true},{"hpoId":"HP:0000739","label":"Anxiety","primary":true},{"hpoId":"HP:0001284","label":"Areflexia","primary":true},{"hpoId":"HP:0010819","label":"Atonic seizure","primary":false},{"hpoId":"HP:0000708","label":"Atypical behavior","primary":false},{"hpoId":"HP:0000729","label":"Autistic behavior","primary":false},{"hpoId":"HP:0012432","label":"Chronic fatigue","primary":false},{"hpoId":"HP:0001289","label":"Confusion","primary":false},{"hpoId":"HP:0000750","label":"Delayed speech and language development","primary":false},{"hpoId":"HP:0000716","label":"Depression","primary":false},{"hpoId":"HP:0002014","label":"Diarrhea","primary":false},{"hpoId":"HP:0002936","label":"Distal sensory impairment","primary":false},{"hpoId":"HP:0012534","label":"Dysesthesia","primary":false},{"hpoId":"HP:0002015","label":"Dysphagia","primary":false},{"hpoId":"HP:0011152","label":"Early onset absence seizures","primary":false},{"hpoId":"HP:0011199","label":"EEG with generalized sharp slow waves","primary":false},{"hpoId":"HP:6000694","label":"Elevated circulating 1-pyrroline-5-carboxylic acid concentration","primary":false},{"hpoId":"HP:6000620","label":"Elevated urinary pyrroline hydroxycarboxylic acid level","primary":false},{"hpoId":"HP:0001298","label":"Encephalopathy","primary":false},{"hpoId":"HP:0003546","label":"Exercise intolerance","primary":false},{"hpoId":"HP:0002373","label":"Febrile seizure (within the age range of 3 months to 6 years)","primary":false},{"hpoId":"HP:0011968","label":"Feeding difficulties","primary":false},{"hpoId":"HP:0002197","label":"Generalized-onset seizure","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0000738","label":"Hallucinations","primary":false},{"hpoId":"HP:0003080","label":"Hydroxyprolinuria","primary":false},{"hpoId":"HP:0003348","label":"Hyperalaninemia","primary":false},{"hpoId":"HP:0002154","label":"Hyperglycinemia","primary":false},{"hpoId":"HP:0003108","label":"Hyperglycinuria","primary":false},{"hpoId":"HP:0008358","label":"Hyperprolinemia","primary":false},{"hpoId":"HP:0002490","label":"Increased CSF lactate","primary":false},{"hpoId":"HP:0002922","label":"Increased CSF protein concentration","primary":false},{"hpoId":"HP:0012402","label":"Increased urine alpha-ketoglutarate concentration","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0011342","label":"Mild global developmental delay","primary":false},{"hpoId":"HP:0003394","label":"Muscle spasm","primary":false},{"hpoId":"HP:0003326","label":"Myalgia","primary":false},{"hpoId":"HP:0000597","label":"Ophthalmoparesis","primary":false},{"hpoId":"HP:0009830","label":"Peripheral neuropathy","primary":false},{"hpoId":"HP:0003137","label":"Prolinuria","primary":false},{"hpoId":"HP:0001345","label":"Psychotic mentation","primary":false},{"hpoId":"HP:0008326","label":"Reduced circulating vitamin B6 circulating","primary":false},{"hpoId":"HP:6000695","label":"Reduced tissue delta-1-pyrroline-5-carboxylate dehydrogenase activity","primary":false},{"hpoId":"HP:0000083","label":"Renal insufficiency","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0000736","label":"Short attention span","primary":false},{"hpoId":"HP:0002360","label":"Sleep disturbance","primary":false},{"hpoId":"HP:0009088","label":"Speech articulation difficulties","primary":false},{"hpoId":"HP:0002133","label":"Status epilepticus","primary":false},{"hpoId":"HP:0002317","label":"Unsteady gait","primary":false},{"hpoId":"HP:0000511","label":"Vertical supranuclear gaze palsy","primary":false}],"ledeHtml":"Hyperprolinemia type 2 results in an excess of a particular protein building block (amino acid), called proline, in the blood. This condition generally occurs when proline is not broken down properly by the body. Hyperprolinemia type 2 causes proline levels in the blood to be 10 to 15 times higher than normal, and it also causes high levels of a related compound called pyrroline-5-carboxylate. Some people with this condition develop mild intellectual disability and seizures; however, the symptoms of this disorder vary in severity among affected individuals.","mondoId":"MONDO:0009401","node":{"canonicalSlug":"hyperprolinemia-type-2","comparisons":[{"documentSha256":"3448f9936310db02e893133cd45ec84c4b7365369b158fa95acf0407b8a37a61","key":"legacy-hyperprolinemia","kind":"legacy","label":"hyperprolinemia","memberIds":["MONDO:0009400","MONDO:0009401","MONDO:0023419"],"mondoId":"MONDO:0023419","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hyperprolinemia.3448f9936310db02e893133cd45ec84c4b7365369b158fa95acf0407b8a37a61.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Hyperprolinemia type 2","originalSourceId":"ORPHA:79101","paragraphs":["Hyperprolinemia type 2 results in an excess of a particular protein building block (amino acid), called proline, in the blood. This condition generally occurs when proline is not broken down properly by the body. Hyperprolinemia type 2 causes proline levels in the blood to be 10 to 15 times higher than normal, and it also causes high levels of a related compound called pyrroline-5-carboxylate. Some people with this condition develop mild intellectual disability and seizures; however, the symptoms of this disorder vary in severity among affected individuals."],"rawAttribution":"MONDO:0009401","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:39:47Z","upstream":"GARD:0006710","url":"https://rarediseases.info.nih.gov/diseases/6710"},"ownColumnKeys":["population-7a1a2fe756052979dbaa","population-78058de8a4512787bff9"],"publication":"published","relationships":[{"kind":"parent","label":"hyperprolinemia","mondoId":"MONDO:0023419","slug":"hyperprolinemia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"009490ec54c237857140f2d2388339fed704c4dba9fee141c9a2ff3246eabf3a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011342","is_excluded":false,"label":"Mild global developmental delay","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"056db1f43462cf06d4f340c093267bf2d5d831c4dcbe5099d4c88ca3b5ea2649","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0009830","is_excluded":false,"label":"Peripheral neuropathy","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"07a800b1a0ed3ad9d73be8388ef90c6e1f0a24166ce49a31ca2c3b0bf95b320f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011152","is_excluded":false,"label":"Early onset absence seizures","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0bc4f0591ecfde28c4ae351c399bdfa438af87644fc637c28807629e719c339e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000083","is_excluded":false,"label":"Renal insufficiency","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"10926405d6afc89f4aae438d900cefffa445ca32015d584946f69cf3a5b6aa09","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002373","is_excluded":false,"label":"Febrile seizure (within the age range of 3 months to 6 years)","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"109da9ff1bb4b086d41e5b9993d5a3d4c605f0a7c618d45f0df978129ee1c46c","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000597","is_excluded":false,"label":"Ophthalmoparesis","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"1db383b77a0b583fd7c94bc6de96f64bf30531c53b2c3804bad25812e14f3412","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:239510","disease_name":"Hyperprolinemia, type II","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"OMIM:239510","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"26129edf91bbb7ff607c3aa2599502eb503c0e182fe8f6a1311a9ec3486d3e25","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2cf31e211a30cd4f95daaf8cb2ada591b7810ec1a27e782e774816ac0a79d6b7","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008358","is_excluded":false,"label":"Hyperprolinemia","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"353d5b5f82a52c93dbe0f94d24a2cc47558e34e08144802d5c78ed49e50729df","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000739","is_excluded":false,"label":"Anxiety","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"39b9d6845dc7d5e305ba7aa0e13bd23c951bd19150a64f201759c6ce5ee9e9e5","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002027","is_excluded":false,"label":"Abdominal pain","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3e96c15d5290b0bfbeddac489a60e61714765d9fb22ebeedbd9a505e7d790557","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003348","is_excluded":false,"label":"Hyperalaninemia","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"42ba20a27935b3cd6c5ee5c7398e836b49679871459f7c59e96b31ca665a49b6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001345","is_excluded":false,"label":"Psychotic mentation","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"47cd07025337e5c66c4b6caf045dc24d507cb965a4becd905d1517905f5b93a1","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003326","is_excluded":false,"label":"Myalgia","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"48fcd76968415f7c519a2a7932e363e4db799ef7563023f3eaa98590677ac178","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011199","is_excluded":false,"label":"EEG with generalized sharp slow waves","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"492c23ce893b0a5199dcf1b5d828fe0b396669ea977a3982e1dee687d2d20062","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5312d34338881a8f05d598a5410c9a86d176bf31e8d2378731e1994a1deae8f6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012534","is_excluded":false,"label":"Dysesthesia","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"563b43b1c32006cca0efe35eff0318612d4e645072878f801c76047da60dffe5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000736","is_excluded":false,"label":"Short attention span","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"57c3e4d56eb1c61238d0ad5ec247ef5191472c646b85e14ca0f63b85251f08bb","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:239510","disease_name":"Hyperprolinemia, type II","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003137","is_excluded":false,"label":"Prolinuria","onset_id":null,"reference":"OMIM:239510","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"60f37c5fea73f413db5fefd6a9eac2dae01585dcb9a31ff4d28b1dbadbb7b6aa","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002015","is_excluded":false,"label":"Dysphagia","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"61c20d973e7fc9a9af66d4c4101a67d6172d36828d273dbd4342c8ac8b2a4829","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:239510","disease_name":"Hyperprolinemia, type II","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003080","is_excluded":false,"label":"Hydroxyprolinuria","onset_id":null,"reference":"OMIM:239510","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"622e6e7f997829a4ae42f93f150be7953b2efca692061dfe23b22e4c13578f53","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:239510","disease_name":"Hyperprolinemia, type II","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:6000620","is_excluded":false,"label":"Elevated urinary pyrroline hydroxycarboxylic acid level","onset_id":null,"reference":"PMID:9700195","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"62d87d658bb79abd290ea1644befa3058abe78dfbb0ce0228f35c6b013b76653","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001289","is_excluded":false,"label":"Confusion","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"648fbe598469db3078bf837789d1b1c8ee717348e7223d219d866ab312fff74b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6bf8fcb73db7cef6c11e53759cf9e7b885075df455e654babce292562dc35b6a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012379","is_excluded":false,"label":"Abnormal circulating enzyme concentration or activity","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"71bc7967f08003c2257def5c828c6dbad6bf09c9d99d8b505a7be951434663ba","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002490","is_excluded":false,"label":"Increased CSF lactate","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8b21838ff91d74bcd0ccd42fd8422e1f73e48ebb360bde1901bcc4fddce5460e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001298","is_excluded":false,"label":"Encephalopathy","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8b46d26b4e0dfc4cc8c6b8e15dde152b6cfd6aef954a78198dcb47a2a4265c61","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9059d39298f004bf64853be6313b1199e235de1f32dbe63c14d700101ce4e51c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002133","is_excluded":false,"label":"Status epilepticus","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"93247d71c693a1d5d6c53e59cadfcb12c78f1332ef14af1a401bd3dc0faeb098","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012402","is_excluded":false,"label":"Increased urine alpha-ketoglutarate concentration","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"93b7c5be0ddc44e4f61d5eb4a8e0555c984d6453766d18e509d48052daa1285f","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000496","is_excluded":false,"label":"Abnormality of eye movement","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"967ce53ecbde59aa81fdf593990865e3b1134ca1e3da35ef0e2c9ff77c56ed29","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002921","is_excluded":false,"label":"Abnormal cerebrospinal fluid morphology","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"97d68a71581e4b3539a3ce7f3311096b5c2406396eeacda5d4a357ab299c2168","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008326","is_excluded":false,"label":"Reduced circulating vitamin B6 circulating","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"98ee9e122f3e222ea1d10f7f490f6472fbb799518ee8f808eeffe7c683dc758c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003394","is_excluded":false,"label":"Muscle spasm","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"99cf3a18d7d2e2e20567034bd070baf8f6012e63e1e6ae66caf70d619a497301","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000716","is_excluded":false,"label":"Depression","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9affcdb101396527f71a0029543b537c42e6df1ccf97887013a6219516ed412c","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a29a998eb8a02f50551329981a6f354dc6d12b1df13057253582d17c98e2d99c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000718","is_excluded":false,"label":"Aggressive behavior","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b3aa59d423bf9970c161cc37ac6fd6a9a7705abd4e1352d8e782d4e8080e3e87","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:239510","disease_name":"Hyperprolinemia, type II","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003108","is_excluded":false,"label":"Hyperglycinuria","onset_id":null,"reference":"OMIM:239510","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"b61139c502bf5ffeda2ee501ef3e9dcac4d5c6fc353d0a580e66c3bcd9e82b16","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0009088","is_excluded":false,"label":"Speech articulation difficulties","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"b93d8266847b8e9100956fee9906a92d3fa826c46d0a9aac56baf924c4ae4c17","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:239510","disease_name":"Hyperprolinemia, type II","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:6000695","is_excluded":false,"label":"Reduced tissue delta-1-pyrroline-5-carboxylate dehydrogenase activity","onset_id":null,"reference":"PMID:2624476","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"bec6c8adfd1329e5e8d53a57144db6e00f8a703cce9b557ce2a411b10cf8ab25","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003137","is_excluded":false,"label":"Prolinuria","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bf432ed20d555d79695f0479e4b76603c2e3241b736e51c4f3cb6aca9347617c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001284","is_excluded":false,"label":"Areflexia","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c17ac089fe86900392ce2837360757fb75441d494357bcdf3f2ef65aa341f815","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010819","is_excluded":false,"label":"Atonic seizure","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c19f043669f43a1d179e80b24d2eb82719f4b0f1e669c4fc712eb3b971f9014d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002154","is_excluded":false,"label":"Hyperglycinemia","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cb71985df8f219f907ddf98a4174842fc2d9324b1c07820964ab9d997525ea27","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012432","is_excluded":false,"label":"Chronic fatigue","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cc8421fc857819bc69872ee6a7b1e41737781ace0dfdb1781aabf2bd2eaefb07","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000708","is_excluded":false,"label":"Atypical behavior","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d9b43559f55b1a6f954ed465cbc2592d085f174a5e585b6bc0521813805fdec8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002197","is_excluded":false,"label":"Generalized-onset seizure","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"da49d892371c699f8f275771bf1a9cc388b0329ef0d264da5448aea6fbdfe80f","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003546","is_excluded":false,"label":"Exercise intolerance","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"da5be1516d3dccdef059af1ed705b8e38f6dbded738e05f92e3606476f1fe6f5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:239510","disease_name":"Hyperprolinemia, type II","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"OMIM:239510","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"e4c57b1742227ae1c0008fdf5e6b7c19dc34d85bc18641f5f55f439c28be5809","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002360","is_excluded":false,"label":"Sleep disturbance","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e755abbb75cd672ffdeaf60ee9fd796c209dbe26447e605cce467a7d5ab75e2c","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000511","is_excluded":false,"label":"Vertical supranuclear gaze palsy","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e9a3c22c26c1621dae59eda59cc01bfba882e51c3b860008d38b9b70d180fff2","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002014","is_excluded":false,"label":"Diarrhea","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e9c228318291c9af7a6e67ebfe7890ccc96bf13fcd511483a2133f6896f09e1b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:239510","disease_name":"Hyperprolinemia, type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:6000694","is_excluded":false,"label":"Elevated circulating 1-pyrroline-5-carboxylic acid concentration","onset_id":null,"reference":"OMIM:239510","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"ea24534cd0c349530b25740d12b4ce4830d63eac84ddfdc0f6ed161120a22079","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000729","is_excluded":false,"label":"Autistic behavior","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ec31fc16fa23d5fe35515fbe8d89385b491b0d0a07a47111c220298e40a29996","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002922","is_excluded":false,"label":"Increased CSF protein concentration","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f4f6f3e39fe7f5b519638b4c450c76f85cd98fd9c3a919547256faa07b00dba1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002936","is_excluded":false,"label":"Distal sensory impairment","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f6c3a173338fd13525bb26e4cfa202b4b385166afd301df75729a9eaeeac83cb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002317","is_excluded":false,"label":"Unsteady gait","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f80de4ecc455a0e46e7f1cdd4a0e184ab3f0d5c9c24a64816feeb570f6854dab","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003080","is_excluded":false,"label":"Hydroxyprolinuria","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f8693de713df1c620f7de8a886c1c6ed69614d0f6cba6d3516a34abf511fad08","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79101","disease_name":"Hyperprolinemia type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000738","is_excluded":false,"label":"Hallucinations","onset_id":null,"reference":"ORPHA:79101","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"f9f92768b0a564d825969d88b041fd07742dbada026c71a225ded31a1c645a46","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:239510","disease_name":"Hyperprolinemia, type II","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0008358","is_excluded":false,"label":"Hyperprolinemia","onset_id":null,"reference":"OMIM:239510","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/6710\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009401\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0006710</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Hyperprolinemia type 2 results in an excess of a particular protein building block (amino acid), called proline, in the blood. This condition generally occurs when proline is not broken down properly by the body. Hyperprolinemia type 2 causes proline levels in the blood to be 10 to 15 times higher than normal, and it also causes high levels of a related compound called pyrroline-5-carboxylate. Some people with this condition develop mild intellectual disability and seizures; however, the symptoms of this disorder vary in severity among affected individuals.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/6710\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"hyperprolinemia-type-2","sourceDocuments":[{"name":"GARD: Hyperprolinemia type 2","reviewed":null,"source_release":"2026-10-25T03:39:47Z","url":"https://rarediseases.info.nih.gov/diseases/6710"},{"name":"MONDO: hyperprolinemia type 2","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009401"}],"sourceNote":"","synonyms":["1 alpha pyrroline-5-carboxylate dehydrogenase deficiency","1-pyrroline-5-carboxylate dehydrogenase activity disease","ALDH4A1 hyperprolinemia","delta-1-pyrroline-5-carboxylate dehydrogenase deficiency","delta1-pyrroline-5-carboxylate dehydrogenase deficiency","disorder of 1-pyrroline-5-carboxylate dehydrogenase activity","HPII","hyperprolinemia caused by mutation in ALDH4A1","hyperprolinemia type 2","hyperprolinemia, type II","HYRPRO2","type 2 hyperprolinemia"],"takeawayHtml":"","title":"hyperprolinemia type 2"},"schemaVersion":1}
